Aim
Patients with aortic aneurysm (AA) may potentially progress into larger dimensions and may be at high risk for lethal complications such as aortic dissection unless they are treated with antihypertensive drugs and restricted from straining and isometric type exercises. Thus earlier detection of aortic aneurysms and treatment of co-morbidities gained importance worldwide. We evaluated the antihypertensive drug preferences in the management of patients with aortic aneurysm and their clinical progress and also the diameter changes from the short term and long term medical recordings.
Material-Method
We retrospectively evaluated medical recordings of 30 patients whose aortic diameters had been measured at short term (2.4±0.6, 2-4 months) and long term (7.3±1.7, 5-11 months) follow up period and also class of antihypertensive drug had been recorded into the archive. Differences (ΔR) were calculated by subtracting 2nd (ΔR short term) and 3rd (ΔR long term) from the 1st measurements of Aortic root (AoR), aortic Sinus (AoS), and ascending aorta (AoAsc). Improvement in aortic diameters was evaluated by comparison short term and long term changes gained at different aortic levels. Additionally aortic diameter changes were evaluated according to the drug preferences.
Material-Method
We retrospectively evaluated medical recordings of 30 patients whose aortic diameters had been measured at short term (2.4±0.6, 2-4 months) and long term (7.3±1.7, 5-11 months) follow up period and also class of antihypertensive drug had been recorded into the archive. Differences (ΔR) were calculated by subtracting 2nd (ΔR short term) and 3rd (ΔR long term) from the 1st measurements of Aortic root (AoR), aortic Sinus (AoS), and ascending aorta (AoAsc). Improvement in aortic diameters was evaluated by comparison short term and long term changes gained at different aortic levels. Additionally aortic diameter changes were evaluated according to the drug preferences.